comparemela.com

Latest Breaking News On - Ashleigh barreto - Page 6 : comparemela.com

Viracta Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesSan diegoIvor roystonEzra cohenAshleigh barretoSilicon valley bankUniversity of californiaHead of investor relations corporate communicationsPrnewswire viracta therapeutics incViracta therapeutics incChief executive officerNorth americaRoyalty purchase agreementViracta therapeuticsPrivate securities litigation reform actRelations contact

Viracta Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today reported financial.

United statesSan diegoIvor roystonEzra cohenAshleigh barretoSilicon valley bankUniversity of californiaHead of investor relations corporate communicationsPrnewswire viracta therapeutics incViracta therapeutics incChief executive officerNorth americaRoyalty purchase agreementViracta therapeuticsPrivate securities litigation reform actRelations contact

Viracta Therapeutics to Host Key Opinion Leader Webinar on Nana-val for the Treatment of Advanced Epstein-Barr Virus-Positive Solid Tumors

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, will host a key opinion leader.

United statesSan diegoEzra cohenAshleigh barretoUniversity of californiaMonitoring committeePrnewswire viracta therapeutics incCancer councilNeck cancer center at mooresNeck cancer centerCancer center executive committeeViracta therapeutics incDepartment of medicineSan diego centerDivision of hematologyGleiberman head

Viracta Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that company.

Ashleigh barretoViracta therapeutics incViracta therapeuticsAnnual needham virtual healthcare conferenceRelations contactInvestor relations

Viracta Therapeutics Announces New Employment Inducement Grant

SAN DIEGO, March 18, 2022 /PRNewswire/ Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies, today announced that the Compensation Committee of. | March 18, 2022

Ashleigh barretoCompensation committee of viracta board directorsPrnewswire viracta therapeutics incViracta therapeutics incCompensation committeeEquity incentive planInducement planNasdaq listing ruleViracta therapeuticsRelations contactInvestor relationsCorporate communicationNc stock exchangePress releaseOmmittee virx us92765f1084

vimarsana © 2020. All Rights Reserved.